Myoblast fusion takes place in two steps in mammals and in
Introduction
Intercellular fusion of myoblasts is a crucial process for somatic muscle formation during embryogenesis of Drosophila and vertebrates, including mammals (Taylor, 2006) . Additionally, in vertebrates, muscle growth after birth requires continuous fusion of myoblasts arising from satellite cells, the stem cells of vertebrate muscles. The somatic musculature of Drosophila melanogaster is well-characterized and can serve as a model in which to study and unravel the underlying molecular mechanisms involved in myoblast fusion.
In Drosophila, myoblast fusion results from a dynamic relationship between founder cells (FCs) and fusion-competent myoblasts (FCMs) (Bate, 1990) . The FCs seed the fusion process and are thus responsible for the unique identity of each muscle fiber. The larger population of FCMs migrate towards, recognize and adhere to the FCs (for reviews, see Abmayr et al., 2005; Baylies et al., 1998; Chen and Olson, 2004; Taylor, 2000) . Following these cellular interaction steps, an FC then fuses with one or two FCMs, giving rise to a precursor cell, which in turn merges with additional myoblasts in a second fusion step until the appropriate muscle size is reached (Bate, 1990; Rau et al., 2001) . Studies on mammalian cell cultures have revealed that there are strong parallels to this model in vertebrates at the molecular level (Horsley and Pavlath, 2004) .
Recently, several essential molecules required for the fusion of FCs and FCMs have been reported. For example, during cell adhesion, membrane-spanning Immunoglobulin (Ig)-molecules are involved in establishing a ring-shaped fusion-restricted myogenicadhesive structure (FuRMAS) . The Ig-domain molecule Dumbfounded [Duf, also known as Kin of Irre (Kirre) (see FlyBase)] (Ruiz-Gomez et al., 2000; Strünkelnberg et al., 2001) forms the ring at cell-contact points in FCs, whereas the Ig-domain protein Sticks and Stones (Sns) (Bour et al., 2000) forms a corresponding structure in FCMs. Both proteins interact heterotypically to initiate the process of myoblast fusion. The progress of fusion is manifested in the expansion of the FuRMAS at the contact sites between FCs and FCMs from 1 μm to 5 μm . Interestingly, the Ig-domain protein Duf was recently identified in zebrafish, suggesting a conserved molecular pathway in insects and vertebrates (Srinivas et al., 2007) .
Other known components of the FuRMAS include the adaptor protein Rolling pebbles7 [Rols7, also known as Antisocial (Ants)] (Chen and Olson, 2001; Menon and Chia, 2001; Rau et al., 2001) in FCs and Blown fuse (Blow) (Doberstein et al., 1997; Schröter et al., 2006) in FCMs. Rols7 induces the second fusion step (Rau et al., 2001) and is expressed as a ring in FCs, similar to Duf, and delivers the signal from the FC membrane into the cytosol by interacting with the intracellular domain of Duf via its tetratricopeptide (TPR) repeats (Kreisköther et al., 2006) . Blow, by contrast, is concentrated as a plug in the center of the ring formed by Sns .
During the fusion process, the actin cytoskeleton of myoblasts is dynamically organized. Consistent with this, the center of the adhesion ring in FCs and FCMs contains filamentous actin (F-actin) . Recently, we reported that the actin regulators kette (Schröter et al., 2004) and wasp (Schäfer et al., 2007) are essential for myoblast fusion. Kette is the Drosophila homolog of HEM2 (NAP1), and can be found in a complex with SCAR (homolog of the mammalian WAVE) and is a member of the Wiskott-Aldrich-syndrome protein (WASP) family (reviewed by Ibarra et al., 2005) . Moreover, kette was shown to interact genetically with blow during myoblast fusion (Schröter et al., 2004) . WASP family members possess a conserved VCA (verprolin homologous, cofilin homologous and acidic) domain, which is involved in the binding of G-actin and Arp2/3 (Rohatgi et al., 1999; Miki and Takenawa, 1998; Machesky et al., 1999) . The wasp 3D3-035 allele lacks the CA domain of the VCA domain and thus neutralizes the function of maternal WASP (Schäfer et al., 2007) . Furthermore, genetic data indicate that Kette antagonizes the function of WASP (Schäfer et al., 2007) . The WASP-interacting partner Verprolin1 [Vrp1, also known as Solitary (Sltr) and Wip; the Drosophila homolog of the mammalian WIP], however, acts in a complex with WASP to ensure successful myoblast fusion (Kim et al., 2007; Massarwa et al., 2007) .
The branching of F-actin is initiated by the de novo nucleation of actin, triggered through the activity of the Arp2/3 complex (reviewed by Takenawa and Miki, 2001) . Alone, the Arp2/3 complex is inactive and requires a set of binding partners, including members of the WASP family, to become active (Machesky and Insall, 1998) . The binding of these proteins has been proposed to lead to a conformational change in the position of the seven subunits of the Arp2/3 complex, especially in the relative position of the subunits Arp2 and Arp3 (Robinson et al., 2001; Volkmann et al., 2001) .
Here, we describe for the first time an EMS-induced Arp3-null allele, Arp3 schwächling , having an abnormal myoblast-fusion phenotype. Ultrastructural analysis of Arp3 schwächling and wasp 3D3-035 revealed the formation of a fusion pore in both mutants. Whereas in Arp3 schwächling mutants the membrane between fusing myoblasts is removed, in wasp 3D3-035 embryos, membrane breakdown is not completed. The finding that fusion in Arp3 schwächling embryos is disrupted despite the formation of a fusion pore indicates that the pore does not expand in Arp3 schwächling mutants. Therefore, to gain a deeper insight into the F-actin regulation of myoblast fusion, we examined Arp3 wasp doublemutant embryos, which show a complete block of myoblast fusion. This phenotype suggests that WASP is not the only actin regulator controlling F-actin polymerization during fusion. Indeed, our studies on scar single mutants and scar vrp1 double mutants strongly imply that the first and the second fusion steps require a different set of F-actin nucleation factors.
Results

schwächling is a new Arp3 allele
The fusion mutant schwächling was detected in the same mutagenesis collection in which we previously identified kette and wasp (Schröter et al., 2004; Schäfer et al., 2007) . Upon analysis of the muscle pattern of the ethyl methane sulphonate (EMS)-induced pointed allele pnt 3D2-26 with the anti-β3-tubulin antibody, we observed an arrest in myoblast fusion. To address whether the mutation in pnt is responsible for the fusion defect, we examined the embryonic muscle pattern of the loss-of-function mutant pnt
Δ88
. However, pnt-null mutants did not show a myoblast-fusion phenotype (data not shown), indicating that the mutation in pnt is not responsible for the observed phenotype. Therefore, it is highly likely that the fusion phenotype is caused by a further mutation on the pnt 3D2-26 -containing chromosome. Complementation tests demonstrated that the additional mutation was not allelic to known mutations in genes required for myoblast fusion, thereby revealing a new fusion-relevant component, which we have named schwächling. To characterize the schwächling mutant phenotype in detail, we separated the pnt locus from the schwächling mutation by using meiotic recombination. Homozygous schwächling mutants display a severe defect in myoblast fusion (Fig. 1B, arrow) .
To map the region in which schwächling is localized, we used the deficiency kit for the third chromosome. The deficiency Df(3L)ZP1 was allelic to schwächling, and both homozygous (Fig.  1C , arrow) and transheterozygous (Fig. 1D, arrow) embryos had a myoblast-fusion defect. Df(3L)ZP1 is a large deficiency (66A17-66C5) resulting in the removal of approximately 90 open reading frames (ORFs). We also found that the deficiency Df(3L)pbl-X1 (65F3-66B10) is allelic to schwächling. To further narrow-down this region, we employed P-element insertions and performed complementation tests. The lethality-causing EP-element insertion Arp66B EP3640 did not complement schwächling. Moreover, the EP insertion Arp66B
EP3640 was mapped to the cytological position 66B6 and was found to be inserted in the 5ЈUTR of the Drosophila homolog of the Arp3 gene Arp66B (FlyBase). We observed that homozygous Arp66B EP3640 mutant embryos do not exhibit a strong myoblast-fusion defect (Fig. 1E) ; however, in transheterozygous Arp66B EP3640 /schwächling embryos, a disruption in myoblast fusion was clearly visible (Fig. 1F, arrow) . These observations suggest that schwächling is a new allele of Arp3; we named this allele Arp3 schwächling . Further support for this finding also comes from RNA in situ hybridizations, which show that the Arp3 transcript is expressed from stage 10 onwards in the mesoderm (Fig. 1G,H ).
Molecular characterization of Arp3 schwächling
To investigate the molecular basis of the EMS mutation in Arp3 schwächling , we determined the sequence of Arp3 in Arp3 schwächling homozygous-mutant embryos. Fig. 1J shows the gene structure of Arp3. In Arp3 schwächling embryos, the Arp3 gene contains a GrA nucleotide transition at the splice acceptor site of the first intron (Fig. 1J ). This point mutation possibly leads to an aberrantly spliced transcript, retaining the first intron, that becomes translated into a truncated protein of 15 amino acids (aa) and can be thus considered as a null allele. To test this notion, RNA was isolated from wildtype, Arp3 schwächling heterozygous and homozygous embryos, and used as template in reverse transcriptase-PCR (RT-PCR) assays. We amplified a 509-bp fragment representing the spliced mRNA form of exons 1 and 3 (Fig. 1I, lower arrowhead) . In Arp3 schwächling heterozygous and homozygous embryos, we additionally obtained a 674-bp product containing the first intron (Fig. 1I , upper arrowhead). However, because this product was present in low amounts, it is highly likely that the spliced form of the product was still present, probably because of the maternal contribution of Arp3 mRNA.
Fusion in Arp3
schwächling is disrupted after precursor formation
Further analysis revealed that the determination of FCs and FCMs in Arp3 schwächling mutant embryos occurs normally (data not shown). Consequently, the phenotype in Arp3 schwächling embryos is due to a failure of myoblasts to fuse. Myoblast fusion in vertebrates and Drosophila proceeds in two distinct steps (Bate, 1990; Beckett and Baylies, 2007; Horsley and Pavlath, 2004; Rau et al., 2001) . During the first step, a bi-to tri-nucleated precursor cell forms, which undergoes additional rounds of fusion until the final size of the mature myofiber is reached. The transcription factor Even skipped (Eve) marks the 14 nuclei of the segmentally repeated dorsal muscle DA1 as well as the pericardial cells. To estimate at which stage of fusion Arp3 schwächling mutant embryos are arrested, we counted the nuclei of the DA1 muscle marked by anti-Eve (Fig. 2B,D) . The DA1 muscles in Arp3 schwächling embryos were found to contain, on average, three nuclei, indicating that the first fusion step, forming a bi-to trinucleated precursor cell, had completed.
Ultrastructural analysis of Arp3
schwächling and wasp
3D3-035 mutant embryos
Arp3 is an actin-related protein that is one of the seven proteins forming the Arp2/3 complex, which is involved in creating new branching actin filaments. The activation of the Arp2/3 complex requires the binding of the WASP family members. In Drosophila, there are two members of this family -WASP and SCAR. Both proteins share a common C-terminal Verprolin homologous (V), Cofilin homologous (C) and acidic (A) domain (also known as the VCA domain). The V domain binds monomeric G-actin and the CA domain binds the Arp2/3 complex (Machesky and Insall, 1998; Miki and Takenawa, 1998; Rohatgi et al., 1999) . Previously, we reported that the lack of the CA and A domain of WASP blocks myoblast fusion after precursor formation (Schäfer et al., 2007) . Thus, in both Arp3 schwächling and wasp 3D3-035 mutants, myoblasts complete the first fusion step, but fail to undergo the second one.
The second fusion step takes place as several distinct steps that can be distinguished at the ultrastructural level (Doberstein et al., 1997; Schröter et al., 2004) . First, electron-dense vesicles appear on adjacent myoblast membranes. This structure is known as the pre-fusion complex (Fig. 2E, arrow) . The vesicles are thought to disintegrate and give rise to the so-called electron-dense plaques (Fig. 2F, arrow) . At the contact area between a precursor cell and an FCM (Fig. 3A ,AЈ, between the arrows), membranes start to vesiculate, initiating the breakdown of the membrane (Fig. 3AЈ,  arrowheads) .
In ultrathin sections of Arp3 schwächling embryos, we observed the formation of a fusion pore between a growing myotube and an FCM ( Fig. 3C, overview; Fig.3CЈ, arrows) . However, we did not observe any plasma membrane remnants between the cells, as seen in wildtype embryos (Fig. 3AЈ , next to the arrowheads). We therefore conclude that Arp3 schwächling embryos stop fusion after membrane breakdown, when a fusion pore has been formed. By contrast, ultrathin sections of wasp 3D3-035 embryos revealed that membrane breakdown fails to complete in these mutants ( Fig. 3B; Fig. 3BЈ , between arrowheads). Hence, wasp is required for the creation of a fusion pore, whereas Arp3 is required to integrate FCMs into the growing myotube after fusion-pore formation.
Journal of Cell Science 121 (8) Recently, two papers have described the identification of a WASP-interacting partner named Vrp1 as an essential component for myoblast fusion (Kim et al., 2007; Massarwa et al., 2007) . To date, two vrp1 alleles, namely wip D30 and sltr
S1946
, are known to stop fusion after precursor formation. Because we observed that wasp 3D3-035 mutants arrest fusion during membrane removal, but that a very different phenotype for vrp1 has recently been reported (Kim et al., 2007) , we reinvestigated the phenotype of vrp1 mutant embryos by electron microscopy. For this purpose, we used the characterized wip D30 allele. Our analysis confirmed that wip D30 mutants (Fig. 3D ,DЈ) are arrested during membrane breakdowna finding also reported by Massarwa et al. (Massarwa et al., 2007) -and that this arrested stage is the same as found in wasp 3D3-035 mutants (Fig. 3B,BЈ) .
WASP is not the only essential activator of the Arp2/3 complex in myoblast fusion
To gain further insight into the relevance of F-actin regulation during myoblast fusion, we generated and investigated Arp3 schwächling and wasp 3D3-035 double-mutant embryos. As described previously, the wasp allele wasp 3D3-035 carries a point mutation that leads to loss of the CA domain of the VCA module (Schäfer et al., 2007) . wasp 3D3-035 mutants show an unfused myoblast phenotype (Fig. 4B,BЈ) . Because the CA domain is essential for binding of the Arp2/3 complex, we predicted that the phenotype of the double mutants would resemble that of wasp 3D3-035 mutant embryos. Instead, we observed a strongly enhanced myoblast-fusion phenotype (Fig.  4C,CЈ) . To analyze the Arp3 schwächling wasp 3D3-035 mutant phenotype more precisely, we examined the DA1 muscle with the nuclear marker anti-Eve. The DA1 muscle was found to only contain one nucleus per hemisegment (Fig. 2C,D) , indicating that fusion is blocked completely in the double mutant. To examine the interaction of Arp3 and wasp during myoblast fusion more closely, we performed the double-mutant analysis with weaker alleles of Arp3 and wasp. This analysis revealed that, in Arp3 schwächling wasp 3 and Arp66B
EP3640
wasp 3D3-035 double mutants, fusion is also blocked completely (data not shown). wasp and Arp3 mRNA are maternally contributed. In the case of wasp, maternal wasp is sufficient to complete myoblast fusion (Schäfer et al., 2007) . We therefore expected that fusion would not be blocked completely, but that the first fusion step, but possibly not the second, would take place in wasp Arp3 double-mutant embryos. The enhanced fusion defect observed in the double mutant led us to propose that wasp is only required during the second fusion step. As a consequence, a different Arp2/3 activator besides WASP must regulate the activity of the Arp2/3 complex during the first step of myoblast fusion.
In addition to the WASP-Vrp1 complex, SCAR also controls Arp2/3-regulated F-actin formation during myoblast fusion
The activity of the Arp2/3 complex is regulated by nucleationpromoting factors such as WASP and SCAR. To determine whether scar is required for myoblast fusion, we examined a hypomorphic and a null allele of Drosophila scar, and generated double mutants with scar and components of the WASP complex.
First we examined the muscle pattern of homozygous scar k13811 and scar Δ37 mutants (Zallen et al., 2002) using the anti-β3-tubulin antibody. We observed a weak fusion defect in these embryos. The unfused myoblast phenotype in homozygous scar Δ37 embryos was more severe than in homozygous scar k13811 mutants (Fig. 5) . Nevertheless, unfused myoblasts were visible in both scar mutants and muscles seemed to be reduced in size in scar Δ37 mutants (Fig.  5E, arrowhead) . We further noticed that dorsal closure is incomplete in both scar mutants. Similar to wasp and Arp3 mRNA, scar mRNA is maternally contributed (Zallen et al., 2002) . This might explain why scar-null mutants still show considerable myoblast fusion. To investigate whether scar and wasp interact genetically during myoblast fusion, we performed a dosis experiment and generated scar wasp double mutants. We used the scar k13811 and wasp 3 alleles, which display only a very weak myoblast-fusion phenotype, for this experiment. Taking out one copy of wasp 3 in a scar k13811 mutant background intensified the appearance of unfused myoblasts (Fig.  5B, arrow) . This phenotype became even more severe in scar k13811 wasp 3 double-mutant embryos (Fig. 5C, arrow) . These findings support our notion that myoblast fusion in Drosophila is regulated via both members of the WASP family. WASP and its interacting partner Vrp1 are both essential for myoblast fusion. Thus, we next examined whether scar and vrp1 also interact genetically.
In addition to the known vrp1 alleles, there is a piggyBac insertion from the Harvard Drosophila stock collection available named vrp1 f06715 . We found that vrp1 f06715 does not complement the deficiencies Df(2R)Exel6078 and Df(2R)Exel7010, and is allelic to wip
D30
. Fig. 5F shows that some fusion takes place in vrp1 f06715 embryos; however, at the end of embryogenesis the growing myotubes are still surrounded by numerous unfused myoblasts. This phenotype is similar to the one observed in wip D30 mutants. To assess the role of the WASP-Vrp1 complex and SCAR during myoblast fusion, we generated scar Δ37 vrp1 f06715 double mutants. Immunostainings of these double mutants with anti-β3-tubulin revealed a dramatically increased myoblast-fusion defect (Fig. 5G ) similar to that observed in Arp3 and wasp double mutants.
Taken together, our double-mutant experiments with scar wasp and vrp1 clearly show that scar and wasp interact genetically during myoblast fusion. Thus, SCAR and the WASP-Vrp1 complex act together during myoblast fusion to regulate the activity of the Arp2/3 complex.
Vrp1 becomes recruited to the tip of filopodia in FCMs, leading to increased F-actin content
To study whether Verprolin is distributed similarly to F-actin during myoblast fusion , we generated an anti-Vpr1 antibody and analyzed the subcellular localization of Vrp1 in embryos carrying the rP298 enhancer-trap insertion. The enhancertrap line rP298 expresses lacZ under the control of the Duf regulatory region, and thus marks all nuclei of the FCs and growing muscles (Nose et al., 1998; Ruiz-Gomez et al., 2000) . Vrp1 was recently reported to localize to specific foci in FCMs (Kim et al., 2007) ; however, we observed that this is only the case in FCMs that have not yet formed a filopodia (Fig. 6AЈ, 
asterisk). After
Journal of Cell Science 121 (8) filopodia formation, however, Vrp1 becomes localized to the tip of the filopodia. In Fig. 6AЈ , the arrowhead points to a dinucleated myotube in which Vrp1 is faintly expressed. Thus, Vrp1 is concentrated like F-actin at the site of cell-cell contact in FCMs, but not at the site of the FCs. To clarify whether the localization of Vrp1 depends on cell contact, we examined the distribution of Vrp1 in an sns-null allele. Although we observed Vrp1 to be still present in sns [20] [21] [22] [23] (Paululat et al., 1995) embryos, the protein could only be found in discrete foci (Fig. 6BЈ, asterisks) . Accordingly, Vrp1 is restricted to the filopodia of FCMs, in which it attaches to an FC/growing myotube. We therefore assume that Vrp1 increases, together with WASP, the formation of F-actin at the tip of the filopodia. The localization of Vrp1 to the filopodia depends on cellcell contact, as revealed by immunostainings with anti-Vrp1 on sns [20] [21] [22] [23] single mutants and on wasp 3D3-035 Arp schwächling double mutants (Fig. 6BЈ asterisk; Fig.6CЈ, asterisk and arrow) . This further shows that the correct localization of Vrp1 in the double mutant is not disturbed because myoblasts are capable of recognition and adherence. When we applied the anti-Vrp1 antibody to vrp f06715 mutant embryos, no staining was detectable, indicating that no protein is generated in vrp1 f06715 embryos. Taken together, we found that Vrp1 becomes restricted to the filopodia formed by the FCMs after successful cell-cell contact.
FCMs fail to fuse after adhesion
To test whether the initial step of recognition and adhesion between FCs and FCMs is indeed not disturbed in Arp3
schwächling and wasp 3D3-035 single mutants, or in the double mutants, we investigated the distribution of Duf in those mutants. In wild-type embryos, we observed the typical ring-like structure in which Duf is distributed (Fig. 7A, arrowhead) . Furthermore, FCMs could be seen contacting growing muscles (Fig. 7A, asterisk) . Fig. 7B shows that, in Arp3 schwächling mutants, several FCMs successfully attached to a precursor cell, but did not become integrated into the precursor cell (asterisks). Also, in wasp 3D3-035 mutants, FCMs were seen to adhere to a growing myotube (Fig. 7C) . These findings are not surprising, because the characterization of the Arp3 schwächling and wasp 3D3-035 mutant phenotypes has already demonstrated that some fusion takes place in both mutants. However, can FCMs that fail to fuse completely in Arp3 schwächling wasp 3D3-035 double mutants attach to FCs or is the failure of fusion in the double mutant due to a secondary effect, e.g. cell migration? Fig. 7D shows that FCMs still find their target, thereby suggesting that no secondary effect is involved (asterisks).
Discussion
The genetic data presented in this study provide new insights into the regulation of branching F-actin during myoblast fusion. There are three classes of protein that initiate the polymerization of new actin filaments: the actin-related protein complex Arp2/3, the Formins and Spire. These protein classes are evolutionary conserved in most eukaryotes and promote new actin assembly by a distinct mechanism. The Arp2/3 complex is the only known protein complex that initiates new actin filaments branching off an existing filament. Upon cell-cell contact, F-actin is mostly present in the tip of the FCM and in the area of the FC/growing myotube to which the FCM is attaching . Our analyses of Arp3, wasp and scar mutants indicate that branching F-actin is essential for myoblast fusion. Based on our double-mutant analyses, we postulate that the WASP-Vrp1 complex promotes branched F-actin formation positively during the second step of myoblast fusion, thereby allowing us to propose a new model for actin regulation during myoblast fusion (see below).
Cell-cell recognition and adhesion occur normally in mutants in which the actin cytoskeleton machinery is affected
This work emanated from the identification of an Arp3-null allele. Fusion is severely disrupted in Arp3 schwächling mutants. However, stainings with anti-Duf clearly show that this is not due to a failure in cell-cell recognition and adhesion. For example, FCMs still attach to the site of the growing myotubes where Duf is expressed in Arp3 schwächling and wasp 3D3-035 mutant embryos. Interestingly, myoblasts also adhere successfully in Arp3 schwächling wasp 3D3-035 double mutants that fail to fuse completely (compare Fig. 1B and Fig. 4B with Fig. 4C ). Duf serves to attract FCMs, which can migrate towards the Duf-expressing source (Ruiz-Gómez et al., 2000) . Hence, the ability of FCMs to migrate is a prerequisite for myoblast fusion. The migration of cells, however, also depends on actincytoskeleton regulation. Our observations clearly show that the nature of the fusion arrest in Arp3 schwächling and wasp 3D3-035 single mutants, and Arp3 schwächling wasp 3D3-035 double mutants, is not due to either the inability of FCMs to migrate nor to a failure of FCs/myotubes and FCMs to recognize and adhere, but rather to a specific defect in cell-cell fusion. WASP is required for the creation of an open fusion pore, whereas Arp3 promotes the integration of the FCMs into the growing myotube Electron microscopy analyses on Arp3 schwächling and wasp 3D3-035 mutants further assisted us to dissect the process in which F-actin formation is required during myoblast fusion. The WASP-Vrp1 complex is involved in the formation of a fusion pore, as reported by Massarwa et al. (Massarwa et al., 2007) . In line with their study, we observed that mutations in wasp 3D3-035 and wip D30 stop fusion during membrane breakdown, but not after pre-fusioncomplex formation, as reported by Kim et al. (Kim et al., 2007) . We found that the pre-fusion complex, which has been described to consist of 1.4 vesicles per pre-fusion complex (Estrada et al., 2007) , looks identical in both of the mutants as well as in wildtype embryos. Fig. 8A presents a new model for myoblast fusion derived from the data presented in this study, Table 1 summarizes the molecules that are required for the fusion process. Our studies on Arp3 mutants indicate that the polymerization-based force of branching F-actin is required beyond the stage of membrane breakdown. After
Journal of Cell Science 121 (8) Blow is localized to the middle of the ring that expresses Sns in FCMs and Duf in FCs. Our data suggest that Vrp1 is also present in this location, inducing the branching of F-actin in concert with WASP. The correct localization of these components is required for the formation of a fusion pore, and hence their presence guarantees successful fusion. Transmission electron microscopy studies suggest that wasp and vrp1 mutants are capable of forming a pore. In Arp3 (encoding a subunit of the Arp2/3 complex) mutants, fusion is disrupted after fusion-pore formation. Therefore, we propose that F-actin is required for the integration of FCMs into the FC/growing myotube. (B) Molecular model for regulating F-actin branching during the first and the second step of myoblast fusion. Duf and Sns form a ring in FCs and FCMs, respectively. The fusion pore will be formed in the middle of the ring (indicated in red). We postulate that the SCARKette complex regulates F-actin formation during the first fusion step. The formation of F-actin during the first fusion step might additionally require the activity of Vrp1. During the second fusion step, the signal from the outer membrane in FCs becomes translated by Rols7, which is involved in the localization of Drosophila Titin (Menon and Chia, 2001) . Our results suggest that F-actin becomes regulated differently in FCs and FCMs. The activity of the actin regulator WASP might be required in FCMs, in which it acts together with Vrp1. We propose that the actin regulators SCAR and Kette are also involved during the second fusion step, because Kette and WASP act antagonistically during the fusion process. Functions of the proteins involved during the first and second fusion step are described in Table 1. membranes have been removed between fusing myoblasts, the FCMs must become integrated into the FC/growing myotube. Because Arp3 schwächling mutants fail to fuse after membrane removal, we propose that F-actin is required to allow integration into the growing myotubes. After the Duf-and Sns-mediated recognition of FCs and FCMs, further essential proteins for myoblast fusion, e.g. Blow, become recruited to the point of fusion in FCMs. We found that Vrp1 localizes in the tip of the filopodia of FCMs. Kim et al. (Kim et al., 2007) and Massarwa et al. (Massarwa et al., 2007) have shown that the localization of WASP to the membrane depends on Vrp1 activity. Thus, the recruitment of WASP presumably leads to an increase of F-actin at the site of fusion. As a result, the formation of a fusion pore is initiated and expands until the FCM becomes finally pulled into the FC/growing myotube.
The Arp2/3 activators WASP and SCAR control F-actin formation during the second step of myoblast fusion, whereas the first fusion step is independent of WASP Our morphological and statistical analysis on the nuclei of the DA1 muscle suggested that no fusion takes place in Arp3 wasp double mutants. Because wasp 3D3-035 mutants should lack the ability to promote F-actin formation and stop fusion, like Arp3 schwächling mutants, after precursor formation, this was a surprising result. We therefore examined whether the actin regulator SCAR additionally controls F-actin branching during myoblast fusion. Double-mutant and epistasis experiments of scar and wasp revealed that this was indeed the case. The complete disruption of myoblast fusion in Arp3 wasp double-mutant embryos -despite the presence of maternal wasp and Arp3 -in conjunction with the finding that SCAR is required for myoblast fusion, led us to propose that SCAR and WASP control different steps of myoblast fusion (Fig. 8B) . So far, our genetic data suggest that WASP is only required during the second fusion step. This is in line with previous data presented by Massarwa et al. (Massarwa et al., 2007) . It further implies that SCAR is essential for the first fusion step. However, myoblast fusion is not disrupted completely in scar
Δ37
-null mutant embryos. The maternally provided gene product of scar is probably able to compensate for the loss of zygotic scar during myoblast fusion. Nevertheless, scar germline clones with reduced levels of maternal and zygotic SCAR protein show an enhanced myoblast-fusion phenotype (Richardson et al., 2007) . Because the loss of maternal scar disrupts oogenesis, it is not possible to eliminate the maternal component of scar completely (Zallen et al., 2002) . Hence, further experiments are required to determine whether SCAR controls the first fusion step alone or acts in functional redundancy with an additional factor.
Myoblast fusion in scar vrp1 double mutants was blocked completely. This might indicate that SCAR regulates the first fusion step together with the WASP-interacting partner Vrp1. The Vrp1 protein is expressed from stage 10 onwards, shortly before the first fusion step is initiated. Members of the Verprolin/WIP family have been reported to influence actin polymerization in a WASPindependent manner (reviewed by Anton and Jones, 2006; Aspenström, 2005) . It remains to be investigated whether this is also the case during Drosophila myoblast fusion.
In addition to regulating the first fusion step, the activity of SCAR might also be required for the second fusion step. Support for this notion comes from our previous findings that the vertebrate homolog of Kette, HEM2, which is present in a complex with SCAR, is essential for myoblast fusion (Schröter et al., 2004) . Kette and WASP have antagonistic functions during myoblast fusion (Schäfer et al., 2007 ). Because we have previously shown that the expression of WASP in FCs failed to rescue the wasp mutant phenotype, one could assume that the activity of WASP is only required in FCMs (Schäfer et al., 2007) . We therefore predict that the polymerization of branching actin filaments might be regulated in a myoblast-type-specific manner (Fig. 8B) .
In summary, our observations suggests for the first time that the cellular machinery leading to the formation of F-actin is controlled by a different set of nucleation-promoting factors during the first and second fusion steps. Future studies should now focus on the mechanistical details to reveal how these factors become activated in FCs and FCMs.
Materials and Methods
Drosophila stocks and genetics
The EMS mutant Arp3 schwächling was mapped using the deficiency kit from the Bloomington Stock Center. We used the following deficiencies and P-insertions to uncover the Arp3 gene (breakpoints are indicated): Df(3L)ZP1 (66A17-66C5), Df(3L)pbl-X1 (65F3-66B10), Df(3L)66C-G28 (66B8-66C10) and Arp66B
EP3640
. We found that Df(3L)66C-G28 is also allelic to schwächling and Arp66B
, suggesting that the distal breakpoint of the deficiency (66B8) is not mapped precisely. Oregon R was used as wild-type strain. We used Dr/TM3 Deformed lacZ and If/CyO hindgut lacZ flies to rebalance our stocks with a blue balancer. Genetic experiments were carried out using the following fly strains: wasp 3 /TM3 (Ben-Yaacov et al., 2001) , wasp 3D3-035 /TM3 (Schäfer et al., 2007) , scar Δ37 /CyO and scar k13811 /CyO (Zallen et al., 2002 
